Cbl-b Is Upregulated and Plays a Negative Role in Activated Human NK Cells

The E3 ubiquitin ligase Cbl-b has been characterized as an intracellular checkpoint in T cells; however, the function of Cbl-b in primary human NK cells, an innate immune anti-tumor effector cell, is not well defined. In this study, we show that the expression of Cbl-b is significantly upregulated i...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of immunology (1950) Vol. 206; no. 4; pp. 677 - 685
Main Authors Lu, Ting, Chen, Li, Mansour, Anthony G, Yu, Melissa J, Brooks, Noah, Teng, Kun-Yu, Li, Zhenlong, Zhang, Jianying, Barr, Tasha, Yu, Jianhua, Caligiuri, Michael A
Format Journal Article
LanguageEnglish
Published United States 15.02.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The E3 ubiquitin ligase Cbl-b has been characterized as an intracellular checkpoint in T cells; however, the function of Cbl-b in primary human NK cells, an innate immune anti-tumor effector cell, is not well defined. In this study, we show that the expression of Cbl-b is significantly upregulated in primary human NK cells activated by IL-15, IL-2, and the human NK cell-sensitive tumor cell line K562 that lacks MHC class I expression. Pretreatment with JAK or AKT inhibitors prior to IL-15 stimulation reversed Cbl-b upregulation. Downregulation of Cbl-b resulted in significant increases in granzyme B and perforin expression, IFN-γ production, and cytotoxic activity against tumor cells. Collectively, we demonstrate upregulation of Cbl-b and its inhibitory effects in IL-15/IL-2/K562-activated human NK cells, suggesting that Cbl-b plays a negative feedback role in human NK cells.
Bibliography:Authors’ Contributions
Administrative, technical or material support (i.e., reporting or organizing data, constructing databases): J. Zhang
Development of methodology: T. Lu, L. Chen, M.J. Yu, N. Brooks and K. Teng
Acquisition of data (provided animals, acquired and managed patients, provided facilities, etc.): T. Lu, L. Chen, M.J. Yu, N. Brooks, K. Teng and Z. Li
Writing, review and/or revision of the manuscript: T. Lu, A.G. Mansour, T. Barr, J. Yu and M.A. Caligiuri
Analysis and interpretation of data (e.g., statistical analysis, biostatistics, computational analysis): T. Lu and J. Zhang
Study supervision: J. Yu and M.A. Caligiuri
Conception and design: T. Lu, J. Yu and M.A. Caligiuri
ISSN:0022-1767
1550-6606
DOI:10.4049/jimmunol.2000177